200,000 buyer hits the board!, page-36

ho hum or crikey mum!! Having read the report again and having spoken to one of the directors last week I am actually feeling much better - the expenses are generally direct "cost of sales" related and there are a number of them in the pipleline, announcements will only be made when they are fully consumated.

The other major cost increase is new staff being taken on, there still remains one or two positions to fill - !!!

The UK activity is building nicely and the road shows are proving very successful. Still would be nice to see more script taken from here to there though.

Profit margings on the MV products are very healthy, they will certainly look a lot healthier when the sales volumes increase thus amortising the costs over a greater base.

Should be news on some sort of general re-structure of the business soon, it has been absorbing some time recently.

Capital raising will be most unlikely this year and the options money is expected to come in, in full!!

They are keen to be seen as having moved away from the Biotech area as this no longer matches their business model and gives possible investors the wrong impression of the business before they really look at it.

Gobsmacked would go someway to explaining how they feel about the current SP, they are completely mystified by the lack of action when they have announced good news.

I made the point quite stridently that more regular updates, details of a business plan, profitability figures on sales, progress reports on various aspects of the business should be punctuating the news releases when sales are completed.

They should also be screaming from the rooftops news of who is on their board!!

All in all I am happy to maintain my long position and more confident than ever that this will be PBI's year.

Good luck to all holders and a gentle nudge to any that are thinking of having a bite of it.

Cheers

Cabe